Skip to main content
. 2023 Jun 19;2023(6):CD013308. doi: 10.1002/14651858.CD013308.pub2

9.2. Analysis.

9.2

Comparison 9: Fixed versus ad lib dose schedule, Outcome 2: Overall serious adverse events